Greenleaf Trust Portfolio holdings
Greenleaf Trust is a privately held, trust-only bank that manages wealth and administers trusts for families. Bill Johnston started it in 1998 after national banks had swallowed up many regional and community banks, wanting a locally owned firm with fiduciary expertise that would serve families across generations. Johnston had already launched a sister firm, Greenleaf Asset Management, in 1991, and the two merged in 2002. The bank builds portfolios around what matters most to each client, whether personal, family-focused or charitable, and avoids selling its own proprietary products. It opened a separate bank, Greenleaf Trust Delaware, in 2018.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$15.9M |
| 2 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
+$8.99M |
| 3 |
Synchrony
SYF
|
+$7.66M |
| 4 |
iShares MSCI EAFE Value ETF
EFV
|
+$6.98M |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$6.49M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Stryker
SYK
|
+$130M |
| 2 |
LLTC
Linear Technology Corp
LLTC
|
+$4.38M |
| 3 |
Gilead Sciences
GILD
|
+$3.72M |
| 4 |
Polaris
PII
|
+$3.44M |
| 5 |
Aflac
AFL
|
+$2.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 82.03% |
| 2 | Miscellaneous | 6.77% |
| 3 | Financials | 2.52% |
| 4 | Technology | 2.32% |
| 5 | Consumer Staples | 1.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Stryker
SYK
$124B
| $3.04B | 79.81% |
25,364,493
-1,127,289
| -4% | -$130M |
2013 Q2
14 quarters
|
|
|
2
iShares Core S&P 500 ETF
IVV
$847B
| $90.3M | 2.37% |
401,509
+72,421
| +22% | +$15.9M |
2013 Q2
14 quarters
|
|
3
iShares Core S&P Small-Cap ETF
IJR
$103B
| $21.3M | 0.56% |
309,878
+97,260
| +46% | +$6.27M |
2013 Q2
14 quarters
|
|
4
State Street Energy Select Sector SPDR ETF
XLE
$40.6B
| $19.4M | 0.51% |
514,712
-9,292
| -2% | -$336K |
2015 Q4
4 quarters
|
|
5
iShares Core S&P Mid-Cap ETF
IJH
$121B
| $18.2M | 0.48% |
548,985
+110,655
| +25% | +$3.51M |
2013 Q2
14 quarters
|
|
6
Apple
AAPL
$4.98T
| $18M | 0.47% |
622,632
-46,216
| -7% | -$1.31M |
2013 Q2
14 quarters
|
|
|
7
iShares MSCI EAFE ETF
EFA
$75.6B
| $17.1M | 0.45% |
296,590
+112,575
| +61% | +$6.49M |
2013 Q2
14 quarters
|
|
8
Chubb
CB
$139B
| $15.7M | 0.41% |
119,174
-17,126
| -13% | -$2.18M |
2013 Q2
14 quarters
|
|
9
PepsiCo
PEP
$193B
| $14.9M | 0.39% |
142,574
-19,872
| -12% | -$2.08M |
2013 Q2
14 quarters
|
|
10
Verizon
VZ
$189B
| $14.1M | 0.37% |
264,055
-7,320
| -3% | -$366K |
2013 Q2
14 quarters
|
|
11
Procter & Gamble
PG
$383B
| $13.7M | 0.36% |
162,893
-779
| -0.5% | -$66.4K |
2013 Q2
14 quarters
|
|
|
CELG
12
DELISTED
Celgene Corp
CELG
| $13.6M | 0.36% |
117,756
-11,205
| -9% | -$1.25M |
2013 Q2
14 quarters
|
|
13
iShares S&P 500 Value ETF
IVE
$49.9B
| $13M | 0.34% |
127,860
-5,165
| -4% | -$504K |
2013 Q2
14 quarters
|
|
14
Alphabet (Google) Class C
GOOG
$3.49T
| $12.9M | 0.34% |
333,620
-1,200
| -0.4% | -$46.7K |
2013 Q2
14 quarters
|
|
15
iShares S&P 500 Growth ETF
IVW
$72.1B
| $12.3M | 0.32% |
402,804
-21,904
| -5% | -$662K |
2013 Q2
14 quarters
|
|
16
Honeywell
HON
$69.7B
| $11.9M | 0.31% |
113,619
+1,703
| +2% | +$173K |
2013 Q2
14 quarters
|
|
|
17
Aflac
AFL
$61.5B
| $11.6M | 0.3% |
332,674
-68,094
| -17% | -$2.4M |
2013 Q4
12 quarters
|
|
|
TCF
18
DELISTED
TCF Financial Corporation Common Stock
TCF
| $11.3M | 0.3% |
207,866
+30,536
| +17% | +$1.49M |
2015 Q2
6 quarters
|
|
19
US Bancorp
USB
$92.6B
| $11.2M | 0.29% |
217,977
-21,367
| -9% | -$1.02M |
2015 Q4
4 quarters
|
|
20
NextEra Energy
NEE
$182B
| $11.2M | 0.29% |
373,944
-15,520
| -4% | -$464K |
2013 Q2
14 quarters
|
|
21
DELISTED
Ansys
ANSS
| $11M | 0.29% |
118,495
-5,465
| -4% | -$503K |
2016 Q1
3 quarters
|
|
22
Sherwin-Williams
SHW
$83.1B
| $10.8M | 0.28% |
120,948
-11,235
| -8% | -$993K |
2015 Q2
6 quarters
|
|
23
Merck
MRK
$362B
| $10.7M | 0.28% |
190,416
-9,041
| -5% | -$529K |
2013 Q2
14 quarters
|
|
24
Lockheed Martin
LMT
$131B
| $10.5M | 0.28% |
42,117
-2,424
| -5% | -$606K |
2016 Q1
3 quarters
|
|
25
Starbucks
SBUX
$120B
| $10.2M | 0.27% |
184,087
+6,762
| +4% | +$375K |
2013 Q2
14 quarters
|
|
Similar funds
Greenleaf Trust's Q4 2016 Portfolio in Review
As of Q4 2016, Greenleaf Trust held 256 positions worth $3.81B, up 0.24% from $3.8B the previous quarter. Its ten largest holdings account for 86% of the portfolio.
Greenleaf Trust's Q4 2016 filing shows 47 new, 84 increased, 80 reduced and 12 closed positions. Its largest new stake was GW Pharmaceuticals Plc American Depositary Shares: 74,686 shares worth $8.35M. The largest sale was Stryker, an estimated $130M.
By sector, the portfolio is most concentrated in Healthcare at 82% of assets, down from 83% a quarter earlier, followed by Miscellaneous and Financials.
- Greenleaf Trust's largest Q4 2016 buy was GW Pharmaceuticals Plc American Depositary Shares: 74,686 shares worth $8.35M.
- Greenleaf Trust added most to iShares Core S&P 500 ETF in Q4 2016, an estimated $15.9M increase.
- Greenleaf Trust's biggest Q4 2016 reduction was Stryker, cutting an estimated $130M.
- Greenleaf Trust fully exited Linear Technology Corp in Q4 2016, selling an estimated $4.38M.
- Greenleaf Trust's ten largest holdings make up 86% of its $3.81B portfolio in Q4 2016.
- Greenleaf Trust opened 47 new positions and closed 12 in Q4 2016.
- Greenleaf Trust's portfolio value rose 0.24% quarter-over-quarter to $3.81B.
Based on Greenleaf Trust's 13F filing for Q4 2016, filed 24 Jan 2017.